Jim Rechtin

Jim Rechtin serves as President and CEO of Humana, the second-largest Medicare Advantage (MA) insurer in the United States, covering approximately 5.5 million Medicare-eligible seniors. Unlike diversified health insurers like UnitedHealth Group and Cigna, Humana is overwhelmingly concentrated on the Medicare population — Medicare Advantage and Medicare Supplement plans generate the vast majority of the company's revenue and profit. Humana's strategy has been to build a vertically integrated model for senior care: the insurance business (Medicare Advantage plans) feeds patients into CenterWell — Humana's healthcare delivery arm that includes primary care clinics, home health services, and a specialty pharmacy. This "payvider" model (combining payer and provider) is designed to improve care quality and reduce costs by controlling more of the care delivery process. The Medicare Advantage industry faces significant headwinds: CMS (Centers for Medicare & Medicaid Services) rate adjustments have not kept pace with rising medical cost trends, Star Quality ratings (which determine bonus payments) have become more stringent, and post-pandemic medical utilization has normalized at higher levels than expected. These pressures have severely impacted Humana's earnings outlook. Key stock drivers include Medicare Advantage membership growth, medical cost trends (medical loss ratio), CMS rate announcements, Star ratings performance, CenterWell growth and profitability, and the regulatory environment for Medicare Advantage.